Latest Xenetic Biosciences Inc. (XBIO) Headlines
Post# of 74
Xenetic Biosciences Announces Opening of Corporate Headquarters and R&D Facility in Lexington, MA
GlobeNewswire - Tue Mar 04, 7:14AM CST
Xenetic Biosciences, Inc. (OTCBB:XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics, today announced the opening of its new corporate headquarters and research and development facility in Lexington, MA. Xenetic, in collaboration with the Massachusetts Life Sciences Center (MLSC) and the Massachusetts Biotechnology Council (MassBio), will host a grand opening and ribbon cutting ceremony today to celebrate the completion of the Company's relocation of its global headquarters to Lexington from London, UK.
Xenetic Biosciences Announces Ticker Symbol Change to XBIO
GlobeNewswire - Fri Feb 14, 6:01AM CST
Xenetic Biosciences, Inc. (OTCBB:XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics, today announced that its common stock has commenced trading under new ticker symbol "XBIO" on the OTC Bulletin Board (OTCBB). Since changing its name in January, the Company has traded on the OTCBB under the ticker symbol "GAIFD."